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INTRODUCTION
A number of interconnected hypothalamic nuclei are involved in
the central control of energy balance. These include the arcuate
nucleus (ARC), ventromedial hypothalamic nucleus (VMH), lateral
hypothalamic area (LH), dorsomedial hypothalamic nucleus (DMH)
and periventricular hypothalamic nucleus (PVN). The ARC and
VMH are exposed to the circulation owing to active transport of
metabolic signals such as leptin, glucose and insulin across the
blood-brain barrier. These signals are then detected in the ARC
and VMH due to the presence of transmembrane receptors. Within
the ARC, there exists two related but exclusive neuronal populations
regulating energy balance: the neurons expressing
proopiomelanocortin (Pomc) and cocaine- and amphetamine-
regulated transcript (Cart), and those expressing neuropeptide Y
(Npy) and agouti related peptide (Agrp). Pomc/Cart neurons are
located within the lateral domain of the ARC and act to inhibit
feeding activity, whereas Npy/Agrp neurons are expressed more
medially, and act to promote feeding. Pomc/Cart neurons are a
heterogeneous population, with distinct subpopulations capable of
responding to different signals, such as leptin via the leptin receptor
(LepR), glucose via glucose-sensitive potassium (K+) channels such
as Sur1 and Kir6.2, and insulin (Cowley et al., 2001; Ibrahim et al.,
2003; Parton et al., 2007; Williams et al., 2010). Furthermore, during
development, Pomc expression is observed in postmitotic neuronal
precursors between embryonic day 10.5 (E10.5) and E14.5, only
50% of which give rise to mature Pomc/Cart neurons, the others
maturing into other ventral hypothalamic subtypes, including
Npy/Agrp arcuate neurons (Padilla et al., 2010).
The other hypothalamic nucleus involved in the primary detection
and integration of systemic information into behavioral response to
control energy balance is the VMH. This nucleus is defined by the
expression of steroidogenic factor 1 (SF1), a nuclear receptor
transcription factor encoded by Nr5a1 that is known for its function
in gonadogenesis and adrenal steroidogenesis (Parker and Schimmer,
1997). SF1 expression is confined to the VMH in the mature
hypothalamus; however, Pomc-expressing postmitotic precursors
also transiently express SF1 during embryonic development (Pelling
et al., 2011). As in the ARC, VMH neurons have been shown to detect
the circulating hormones leptin, glucose and insulin (Dhillon et al.,
2006). The deletion of LepRs in SF1-expressing cells results in adult-
onset obesity with an associated reduction in energy expenditure
prior to the onset of obesity (Bingham et al., 2008).
Although the importance of ARC and VMH neurons in the
control of feeding and activity is well established, little is known
about their development. This is potentially important, because
there are variations in the incidence of obesity in populations in
the developed world that experience similar diet and lifestyles,
suggesting the existence of still-unknown genetic and/or
developmental influences on the tendency to develop obesity
(Ramachandrappa and Farooqi, 2011). Recent studies in rodents
have demonstrated that the maternal diet during gestation and
lactation has an influence on the later expression levels of the
arcuate-derived neuropeptides involved in feeding in the offspring
(Chen et al., 2008; Chen et al., 2009). The development and genetic
basis of human obesity is still poorly understood (Ramachandrappa
and Farooqi, 2011). Further knowledge might help in the prevention
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SUMMARY
The ventral hypothalamus acts to integrate visceral and systemic information to control energy balance. The basic helix-loop-helix transcription
factor neurogenin-3 (Ngn3) is required for pancreatic β-cell development and has been implicated in neuronal development in the hypothalamus.
Here, we demonstrate that early embryonic hypothalamic inactivation of Ngn3 (also known as Neurog3) in mice results in rapid post-weaning obesity
that is associated with hyperphagia and reduced energy expenditure. This obesity is caused by loss of expression of Pomc in Pomc- and Cart-expressing
(Pomc/Cart) neurons in the arcuate nucleus, indicating an incomplete specification of anorexigenic first order neurons. Furthermore, following the
onset of obesity, both the arcuate and ventromedial hypothalamic nuclei become insensitive to peripheral leptin treatment. This conditional mouse
mutant therefore represents a novel model system for obesity that is associated with hyperphagia and underactivity, and sheds new light upon the
roles of Ngn3 in the specification of hypothalamic neurons controlling energy balance.
Conditional deletion of neurogenin-3 using Nkx2.1iCre
results in a mouse model for the central control of
feeding, activity and obesity
Neal Anthwal1, Michelle Pelling1, Suzanne Claxton1, Georg Mellitzer2,*, Caitlin Collin2, Nicoletta Kessaris3, 
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and treatment of obesity and its associated metabolic disorders,
such as type 2 diabetes. In addition to understanding the genetic
basis of obesity, mechanistic insights into the development of the
hypothalamus will illuminate how the developmental environment
is able to influence the activity of the adult hypothalamus.
The basic helix-loop-helix (bHLH) transcription factor
neurogenin-3 (Ngn3) is an important player in the development
and specification of the endocrine control of energy balance in mice.
Ngn3 acts with its partner, Pdx1, in the specification of insulin-
producing β-cells in the pancreas (Gradwohl et al., 2000; Gasa et
al., 2004; Schonhoff et al., 2004; Smith et al., 2004; Johansson et al.,
2007). It also acts to specify the endocrine cells of the gastric and
intestinal epithelium (Jenny et al., 2002). An intestine-specific
deletion of Ngn3 (also known as Neurog3) in mice results in a failure
to produce a number of gut enzymes, including those involved in
lipid metabolism, resulting in a lean phenotype and death in early
adulthood from malnutrition (Mellitzer et al., 2010). Furthermore,
there are a number of reported point mutations of NGN3 in humans
that result in severe neonatal malabsorptive diarrhea and infant
diabetes (Wang et al., 2006; Pinney et al., 2011).
Lineage studies indicate that Ngn3-expressing cells contribute to
ventral hypothalamic areas such as the ARC and VMH (Pelling et
al., 2011), but not to the more dorsal DMH or PVN (data not
shown). We have previously described a role for Ngn3 and another
bHLH transcription factor, Ascl1 (also known as Mash1), in the
development of the mouse hypothalamus (McNay et al., 2006;
Pelling et al., 2011). Interestingly, Ngn3 regulates the development
of ARC nucleus neurons. Loss of Ngn3 in mice results in an increase
in the number of Npy+ neurons, accompanied by a severe loss of
Pomc+ neurons. However, Ngn3-null mutant mice die shortly after
birth owing to the role of Ngn3 in pancreatic β-cell specification,
and the consequence of Ngn3 deletion in the developing
hypothalamus upon the behavior of adult mice could not be
assessed. In the present study, we use a conditional knockout system
to specifically delete Ngn3 from the ventral forebrain, resulting in
a depletion of Pomc expression in ARC neurons, a decrease in leptin
sensitivity in the ARC and VMH nuclei, and an associated obesity
due to hyperphagia and reduced energy expenditure. Using this
new conditional Ngn3 mouse model, we also demonstrated that
Ngn3 is required for the expression of Pomc and nescient helix loop
helix 2 (Nhlh2), but not for the expression of Cart in most
Pomc/Cart neurons.
RESULTS
Generation of Ngn3 conditional-knockout mice
To study the consequence of the loss of Ngn3 in the developing
hypothalamus on energy balance in adult animals, we used iCre driven
by the Nkx2.1 promoter to delete Ngn3 in Nkx2.1iCre/+;Ngn3flox/flox
mice. The domain of Ngn3 deletion was confirmed by crossing
Nkx2.1iCre/+ mice with R26R homozygous mice, which contained
floxed lacZ alleles in the Rosa26 locus (Soriano, 1999) in order to
trace the location of iCre recombinase activity. Embryos were
dissected and stained with X-Gal solution to reveal the presence of
the lacZ reporter. In the developing CNS, strong β-galactosidase (β-
gal) expression was seen in the ventral forebrain as early as E9.25,
similar to the onset of expression of Nkx2.1 (Kimura et al., 1996;
Sussel et al., 1999) and also of Ngn3 (Fig. 1A). In the mature nervous
system, β-gal expression was observed throughout the hypothalamus,
including the ARC, VMH and lateral hypothalamic area (Fig. 1A).
β-gal expression was also seen in the developing gut endoderm and
lung anlage. In order to confirm that Ngn3 deletion was restricted
to the forebrain, quantitative reverse-transcriptase PCR (qRT-PCR)
for Ngn3 was carried out on E15.5 pancreatic tissue (Fig. 1C), and
in situ hybridization for Ngn3 was carried out on the adult small
intestine. Ngn3 expression in these two endodermal tissues of
Nkx2.1iCre/+;Ngn3flox/flox mice was the same as seen in these tissues
in control littermates (Ngn3flox/flox) (Fig.  1D). Furthermore, adult
Nkx2.1iCre/+;Ngn3flox/flox mice did not exhibit the gut and pancreas
abnormalities associated with a null mutation of Ngn3. In order to
confirm brain deletion of Ngn3, we analyzed Ngn3 expression by in
situ hybridization of E9.5 control and Nkx2.1iCre/+;Ngn3flox/flox
embryos. Whereas control embryos showed Ngn3 expression in
ventral hypothalamic progenitors, no signal was detected in the same
region of Nkx2.1iCre/+;Ngn3flox/flox embryos. Further confirmation
of deletion was sought by qRT-PCR analysis of Ngn3 expression in
dmm.biologists.org1134
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TRANSLATIONAL IMPACT
Clinical issue
The prevalence of obesity in Western societies is reaching epidemic
proportions. Although diet and lifestyle are the main contributors to the rise in
obesity, variation within populations indicates that the genetic and
developmental environment can influence an individual’s susceptibility to
obesity. The hypothalamus is an area in the brain that is involved in the
regulation of energy balance. Despite advances in our understanding of its
role, relatively little is known about hypothalamic development. The
transcription factor neurogenin-3 (Ngn3) has been implicated in neuronal
development in the hypothalamus. Enhancing our understanding of the
mechanisms underlying hypothalamus development via studies in mice will
shed light on the role of embryonic development in human obesity.
Results
In this work, the authors present a novel mouse model of obesity. The model
was generated by hypothalamic deletion of Ngn3 (also known as Neurog3),
which results in rapid post-weaning obesity, concomitant with increased food
intake (hyperphagia) and reduced energy expenditure. Because Ngn3 is an
important factor in insulin-producing pancreatic β-cell development, global
mutants for Ngn3 die shortly after birth owing to severe diabetes. However, in
the model presented here, the genetic insult is restricted to the brain, so these
mice are born with normal insulin production. Following the onset of obesity,
mutant mice develop insulin resistance, increased glucose tolerance, and
changes in blood biochemistry such as increased leptin, adrenocorticotropic
hormone and insulin levels. The authors identified the primary cause of
obesity as loss of hypothalamic Pomc expression, which is known to induce
hyperphagia, whereas other energy-balance-related hypothalamic peptides
were unaffected. The authors also identified changes that could mediate the
reduction in energy expenditure in obese mice, notably insensitivity of the
ventromedial hypothalamus to leptin.
Implications and future directions
These data indicate that Ngn3 is likely to have roles in specifying hypothalamic
control of both sides of the energy balance equation. Further analysis will
provide mechanistic insights into the role of Ngn3 in the specification of the
hypothalamus. Ngn3 and its currently undefined targets represent promising
candidates for the prevention of developmentally determined obesity. The
current study also provides a novel obesity model in which extreme levels of
obesity are achieved with no impact on peripheral tissues. As such it offers an
improved system compared with classical models such as the leptin-signaling-
deficient ob/ob and db/db mice. Similarly, the model facilitates the study of
Pomc disruption specifically in the hypothalamus, circumventing the global
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dissected ventral forebrain tissue at E9.5 and E10.5. qRT-PCR
revealed a residual Ngn3 expression in the ventral forebrain of
Nkx2.1iCre/+;Ngn3flox/flox at E9.5 (Fig.  1B), whereas, by E10.5,
expression levels were reduced to background level.
Hypothalamic Ngn3 deletion results in early-onset obesity
accompanied by hyperphagia and reduced adult activity
We have previously shown a severe loss of Pomc+ neuronal
number followed by increased numbers of Npy+ neurons in the
ARC of Ngn3−/− embryos during development (Pelling et al., 2011).
Owing to the importance of these circuits in energy balance, we
therefore investigated the body mass, food intake and energy
expenditure of Nkx2.1iCre/+;Ngn3flox/flox mice. In contrast to the
conventional knockout of Ngn3, Nkx2.1iCre/+;Ngn3flox/flox mice
survived to adulthood, with no apparent increase in juvenile
mortality. At weaning, control and mutant mice were
morphologically similar; however, shortly after weaning mutant
mice rapidly became obese, with homozygous mutant mice being
Disease Models & Mechanisms 1135
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Fig. 1. Nkx2.1iCre drives Ngn3 deletion in the ventral forebrain. (A)Expression of Nkx2.1iCre in the developing mouse embryo. R26RLacZ reporter females
were crossed with Nkx2.1iCre males, and resulting embryos stained with X-Gal to reveal lacZ reporter expression. β-gal-positive cells are observed in the ventral
forebrain as early as E9.25 and throughout the adult hypothalamus. β-gal-positive cells are also observed in endodermal-derived tissues from around E10.0.
Insert represents angle of section throughout study. m, midline; 3v, third ventricle; vHy, ventral hypothalamus. (B)Ngn3 was conditionally deleted in Nkx2.1-
expressing cells by crossing Nkx2.1iCre males with Ngn3flox/flox females, resulting in Ngn3 conditional mutant mice (Nkx2.1iCre/+;Ngn3flox/flox). Following deletion,
Ngn3 expression was not observable by in situ hybridization at E9.5. However, qRT-PCR reveals low levels of Ngn3 in the E9.5 ventral forebrain, whereas only
residual levels are seen at E10.5. Student’s t-test: *P<0.05 and ***P<0.005. (C,D)Despite iCre-positive cells being observed in the developing endoderm, no
change was seen in the expression of Ngn3 by in situ hybridization in the adult intestinal crypt cells (C), nor by qRT-PCR in the developing pancreas (D).
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significantly heavier than control and Nkx2.1iCre/+;Ngn3flox/+
littermates by postnatal week 5 (Fig. 2A,B). This weight gain
continued well into sexual maturity, with both male and female
mice being fertile and capable of producing viable offspring. The
difference in mass was more pronounced in females than in males,
and the rate of increase in body weight also continued at a greater
rate in females (Fig. 2C). Mutant mice (n=3) were pair-fed against
control littermates between 4 and 6 weeks of age. The mean weekly
increase in body weight was significantly high in ad libitum-fed
mutant animals when compared with control littermates, whereas
pair-fed mutant animals showed no difference to control
littermates (Fig. 2D). A cohort of 18 control (9 male and 9 female)
and 18 mutant (9 male and 9 female) mice were analyzed for
differences in metabolism and physiology (n=9 for each sex and
genotype). Body weights were recorded once a week from the age
of 12 to 22 weeks. In this group, both male and female mutant
mice displayed significantly higher body weights compared with
controls, and the difference was more pronounced in females than
in males. In order to ascertain body composition, quantitative
nuclear magnetic resonance (qNMR) imaging was carried out at
14 weeks of age (Fig. 2E). The proportion of body weight made
up of fat mass was increased, whereas the proportion of lean mass
decreased. The total mass of lean tissue increased slightly but
significantly. Taken together, these data demonstrate that elevated
body mass is mainly due to an increase in adipose tissue (Fig. 2E).
The proportion of body weight made up of free fluid mass was
significantly decreased in mutant females compared with controls,
whereas no such difference was observed in males (Fig. 2E). At 12
weeks of age, daily food intake was measured. Following 7 days of
experimental habituation, the difference in daily food intake was
significantly higher in both male and female mutant mice
compared with controls (Fig.  2F). The cumulative weekly food
dmm.biologists.org1136
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Fig. 2. Nkx2.1iCre/+;Ngn3flox/flox mice become viscerally
obese and are hyperphagic. (A)Examples of control (left)
and conditional mutant (right) 8-week-old female littermates.
(B,C)Mutant Nkx2.1iCre/+;Ngn3flox/flox mice become
significantly heavier than control and Nkx2.1iCre/+;Ngn3flox/+
littermates from postnatal week 5 (around 1 week after
weaning), and continue to gain mass well into mature adult
stages. The rate of weight gain is more rapid in females than
males (C). (D)Ad libitum-fed Nkx2.1iCre/+;Ngn3flox/flox mice gain
more weight per week between 4 and 6 weeks of age than do
Nkx2.1iCre/+;Ngn3flox/flox mutants pair-fed to control
littermates. (E)Body weight, fat mass, lean mass and free body
fluids (FBF) presented as percentage body weight (%) and as
total mass (g) in 14-week-old control and mutant male and
female mice. Body weight and proportion of body mass made
up of fat tissue is significantly increased in mutant animals,
whereas the percentage lean mass is reduced. The percentage
free body fluid is significantly reduced in female mutant mice
compared with controls, but not in males. (F)Both male and
female Nkx2.1iCre/+;Ngn3flox/flox mice show a significant
increase in daily and cumulative weekly food intake. Student’s
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intake was significantly higher in mutant mice (Fig.  2F) and,
although significance was achieved in both male and female mice,
the increase was larger in males.
Energy expenditure was evaluated by indirect calorimetry and
measurement of ambulatory activity in the same cohort at 17 weeks
(n=9 for each sex and genotype). Both male and female mutant
mice displayed a reduction in oxygen consumption and carbon
dioxide production (Fig. 3A-D). In males, oxygen consumption
(VO2) tended to be lower, particularly during the night (Fig. 3A)
and carbon dioxide production (VCO2) was significantly lower
(Fig. 3C). In addition, male mutant mice showed a lower respiratory
exchange ratio (RER) than controls (Fig. 3E). Female mutant mice
displayed significantly lower VO2 and VCO2 levels than the controls
both during the day and night period (Fig. 3B,D), but their RERs
were similar to the controls (Fig. 3F), in part owing to variability
within the mutant group. Ambulatory activity and total movements
were lower in both male and female mutant mice compared with
controls during the dark phase, but not during the light phase
(Fig. 3G,H), as was heat production (Fig. 3I,J).
Taken together, these data demonstrate that loss of Ngn3 during
development leads to rapid post-weaning obesity associated with
hyperphagia and reduced energy expenditure.
Hypothalamic deletion of Ngn3 results in insulin insensitivity and
altered blood biochemistry
Owing to the role of Ngn3 in glucose homeostasis, and the association
of obesity with endocrine disorders such as type 2 diabetes, we next
investigated in Nkx2.1iCre/+;Ngn3flox/flox mice the glucose/insulin
response system as well as a number of other hormones associated
with obesity (in the same cohort of n=9 for each sex and genotype).
Following glucose and insulin challenge, mutant mice were
significantly more intolerant of glucose compared with controls
(Fig. 4A,B), with the effect being more pronounced in females than
in males. Insulin challenge revealed that female mutant mice were
Disease Models & Mechanisms 1137
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Fig. 3. Nkx2.1iCre/+;Ngn3flox/flox mutant mice exhibit decreased
energy expenditure at 17 weeks of age compared with controls.
(A,B)Oxygen consumption in male and female mice. There is a trend
for decreased oxygen consumption in mutant male mice compared
with control mice particularly in the night-time dark phase (A),
whereas, in female mutant mice, oxygen consumption if significantly
reduced compared with controls (B). (C,D)CO2 production is
significantly reduced in both male (C) and female (D) mutant mice
compared with control littermates. (E,F)Respiratory exchange ration
(RER) is significantly lower in male mutant mice compared with
controls (E); no difference is observed in females (F). (G,H)Movement,
measured by total movement (G) and ambulatory activity (H), is
significantly reduced in mutant mice during the dark phase but not
during the light phase. (I,J)There is a reduction in heat production in
mutant mice. Male mice show a trend of reduced heat production
compared with controls, particularly in the dark phase (I), whereas
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significantly more insensitive to insulin compared with controls,
whereas male mice show elevated insulin tolerance but not as to reach
statistical significance (Fig.  4C). Furthermore, blood analysis
demonstrated that male mutant mice had significantly elevated blood
insulin compared with controls, with female mice showing a large
difference approaching significance (Fig.  4D). Blood leptin was
significantly increased in both male and female mutant animals
compared with controls (Fig.  4E), due to increased body fat.
Conversely, no change in adiponectin was detected in either sex
(Fig.  4F). Compared with controls, peptide YY (Pyy) levels were
increased in both males and females, but not as to reach statistical
significance (Fig. 4G). This is in part due to a high standard deviation
in mutant sample, particularly in male mice. Levels of
adrenocorticotropic hormone (Acth), a Pomc product released by
the pituitary, were significantly higher in mutant female mice than
in controls, and were elevated, but not statistically significantly so,
in males (Fig. 4H). This data suggests that Pomc expression, and hence
Acth production, is deregulated in the pituitary as a consequence 
of the loss of Ngn3 expression in Acth-secreting pituitary cells.
However, nuclear expression of Ngn3 is not detectable by
immunohistochemistry in the pituitary, and qRT-PCR expression
suggests that, when present, Ngn3 is expressed at only very low levels
(Fratticci et al., 2007). It is therefore unlikely that loss of Ngn3 in the
pituitary is responsible for the elevation of serum Acth, and so an
indirect cause must be sought.
Arcuate Nhlh2 expression is absent in Nkx2.1iCre/+;Ngn3flox/flox
mice
Nhlh2 is a bHLH transcription factor expressed in the developing
and adult hypothalamus, including in the ARC. Nhlh2-null mice
dmm.biologists.org1138
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Fig. 4. Nkx2.1iCre/+;Ngn3flox/flox mice display reduced glucose
tolerance and insulin sensitivity, and show changes in blood
hormone levels compared with controls. (A,B)Intraperitoneal
glucose tolerance test (IPGTT). White squares, mutants; black
squares, controls. Female mutant mice showed significantly higher
glucose levels at all time points of the test, whereas, in male mutants,
levels were not significantly higher immediately following injection;
however, the glucose decrease following glycemic peak is slower (A).
Female mutant mice showed significantly higher area under glucose
curve (AUC) than controls (B). (C)Insulin sensitivity test (IPIST).
Female mutant mice are significantly insulin resistant, whereas male
mice do not reach significance. (D-H)Blood insulin, leptin, Pyy and
Acth levels are increased in mutant mice (D,E,G,H), whereas
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become obese at postnatal week 8 (Coyle et al., 2002), and we have
previously demonstrated reduced expression of Nhlh2 in Ngn3-null
mice (Pelling et al., 2011). Nhlh2 expression was severely reduced
in Nkx2.1iCre/+;Ngn3flox/flox mutants. We determined the
expression of Nhlh2 by in situ hybridization in hypothalami of
embryonic and adult Nkx2.1iCre/+;Ngn3flox/flox mutants. Deletion
of Ngn3 in the ventral forebrain resulted in loss of Nhlh2 expression
in the presumptive hypothalamus at E10.5 and E13.5 (Fig. 5A-D).
Although sparse Nhlh2 expression was transiently observed in E17.5
embryos (Fig.  5E,F), expression of this gene was absent in adult
mutants (Fig. 5G,H). These results confirm earlier studies (Pelling
et al., 2011) and further indicate that Nhlh2 expression is lost in
the adult hypothalamus in the absence of Ngn3 activity during
embryonic stages.
Deletion of Ngn3 results in a reduction in the number and
incomplete specification of Pomc/Cart neurons
We have previously demonstrated that Ngn3-null mutant embryos
show a substantial reduction of postmitotic Pomc+ cells from the
initial expression at E10.5, with the perinatal (E17.5) number of
Pomc+ neurons being 60-70% of that seen in wild types (Pelling et
al., 2011). In the present study, Nkx2.1iCre/+;Ngn3flox/flox embryos
showed a similar reduction of hypothalamic Pomc+ postmitotic
neurons during embryonic development (supplementary material
Fig. S1). The reduction in Pomc+ cells remained into adulthood in
Nkx2.1iCre/+;Ngn3flox/flox mice, with the total number of neurons
being around 20% of that seen in control hypothalami (Fig. 6A,B,E).
Compared with controls, no substantial difference was observed
in the number of Pomc+ cells in the ARC of male or female mutant
mice. Importantly, expression of the Pomc product α-melanocyte
stimulating hormone (αMsh) was almost completely abolished in
mutants, with only a few expressing cells being observed
throughout the ARC (supplementary material Fig. S2). Ngn3-null
mice also displayed an accompanying increase in Npy+ cells in the
ARC that is suggestive of a change in fate of developing ARC cells
from Pomc-expressing to Npy-expressing (Pelling et al., 2011).
However, Nkx2.1iCre/+;Ngn3flox/flox mutant embryos or adult mice
did not exhibit any difference in the number of Npy-expressing cells
compared with controls, although the pattern of Npy expression
was less compacted in Nkx2.1iCre/+;Ngn3flox/flox adult mice
compared with control mice (Fig. 6C,D,F; supplementary material
Fig. S1). Furthermore, despite the reduction in Pomc+ cells and the
normal number of Npy+ neurons in the adult hypothalamus, there
was no obvious change in the cytoarchitecture of the hypothalamus
(data not shown).
We next determined whether the loss of Pomc expression was
due to gene regulation or to a loss of neurons. Cart transcripts
were found in the Pomc-expressing neurons of the ARC of adult
control mice. In Nkx2.1iCre/+;Ngn3flox/flox mice, Cart expression
was maintained in the ARC (Fig. 7A-C). To further probe the
identity of the Cart+ cells, double-fluorescent in situ hybridization
for Cart and Pomc, and for Cart and Npy, was carried out. Many
Cart+ cells in the ARC of Nkx2.1iCre/+;Ngn3flox/flox mice did not
coexpress Pomc, whereas all arcuate Cart+ neurons coexpressed
Pomc in control mice (Fig. 7A,B). Furthermore, as in the control
mice, there was no overlap of Cart and Npy transcript expression
in the mutant ARC (Fig. 7A,B)
A proportion of Pomc+ arcuate neurons also express the
endogenous opioid dynorphin (Maolood and Meister, 2008), which
itself is implicated in energy balance and whose expression is
sensitive to leptin levels (Levin and Dunn-Meynell, 2002; Silva et
al., 2002). In situ hybridization for Pdyn, the gene encoding the
dynorphin protein, was carried out in adult control and conditional
mutant hypothalamic sections (Fig. 7D,E). Expression of Pdyn was
substantially reduced throughout the hypothalamus, not only in
the ARC but also in the VMH and the DMH hypothalamus. Because
the DMH is not derived from Ngn3+ progenitors (data not shown),
it is likely that the reduction in Pdyn expression is secondary to
elevated blood leptin. The ARC also includes a population 
of tyrosine hydroxylase (TH)-expressing dopaminergic
neuroendocrine cells, the number of which is increased in Ngn3-
null mutants (Pelling et al., 2011). However, in situ hybridization
for Th mRNA revealed that there was no obvious change in 
the number of dopaminergic neurons in the ARC of
Nkx2.1iCre/+;Ngn3flox/flox mutants (see supplementary material Fig.
S2A,B). The ARC is also an important part of the hypothalamic-
pituitary-gonadal axis, and includes a population of estrogen
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Fig. 5. Expression of Nhlh2 in the hypothalamus of developing and adult
Nkx2.1iCre/+;Ngn3flox/flox mice. In situ hybridization reveals that Nhlh2
expression is absent in the early embryonic hypothalamus of mutant mice (A-
D). In late development, a few Nhlh2-positive cells are observed per section
(E,F; arrows); however, no expression is observed in the adult mutant ARC















    
   D
M
M
receptor-α (ERα)-expressing neurons, a subset of which colocalize
with Pomc+ neurons (de Souza et al., 2011). To determine whether
the expression of ERα is affected in Nkx2.1iCre/+;Ngn3flox/flox mice,
fluorescent immunohistochemistry was carried out (see
supplementary material Fig. S2C,D). No difference was observed
in the pattern or intensity of staining at the level of the ARC between
control and mutant mice. These expression patterns (Th, Pdyn, Cart
and ERα) were similar in both male and female mice of both
genotypes.
In summary, neurons expressing Pomc were reduced by 80% in
the ARC of Nkx2.1iCre/+;Ngn3flox/flox mice, and the Pomc subset
marker Pdyn was severely reduced, whereas Cart expression was
not affected. Expression of other arcuate markers – Npy, Th and
ERα – were unchanged.
dmm.biologists.org1140
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Fig. 6. Expression by in situ hybridization of 
Pomc and Npy in the hypothalamus of
Nkx2.1iCre/+;Ngn3flox/flox and control mice.
(A-D)Anorexigenic Pomc expression compared with
the expression in control mice is reduced in the ARC
(A,B), whereas orexigenic Npy expression is
unchanged (C,D). (E,F)Quantification of the number
of Pomc- and Npy-expressing neurons in the ARC of
Nkx2.1iCre/+;Ngn3flox/flox mice compared with control
mice. The number of Pomc+ cells is reduced by
around 80% in Nkx2.1iCre/+;Ngn3flox/flox mutant mice
(E), whereas the number of Npy+ cells is unchanged
(F). Student’s t-test: NS, not significant; **P<0.01.
Fig. 7. Analysis of Cart and Pdyn expression by in situ
hybridization, and of pSTAT3 by immunohistochemistry,
in Nkx2.1iCre/+;Ngn3flox/flox and control mice. 
(A-E)Hypothalamic expression analyzed by in situ
hybridization of Cart and Pdyn in adult
Nkx2.1iCre/+;Ngn3flox/flox mice. (A,B)Cart expression is largely
unchanged in mutant mice compared with controls.
Double-fluorescence in situ hybridization (a,b) shows that
Cart is always coexpressed with Pomc in the ARC of control
mice, whereas both Cart/Pomc double-labeled cells
(arrowheads) and Cart single-labeled cells are observed in
the mutant condition. Cart is never coexpressed with Npy in
control or mutant mice. (C)Quantification by cell counting
shows that the number of Cart+ cells in adult mutant mice is
unaffected. (D,E)Expression of Pdyn, the gene encoding the
opioid dynorphin, is reduced in the VMH, DMH and ARC,
where it is coexpressed by a subset of POMC+ neurons, in
the conditional mutant mice compared with controls. 
(F-M)Immunohistochemical analysis of the expression of
pSTAT3 following leptin challenge in 4-week- and 12-week-
old Nkx2.1iCre/+;Ngn3flox/flox mutant mice. pSTAT3 is a
intracellular effector of LepR. (F,G,J,K) Expression is
unaffected in the ARC (F,G) and VMH (J,K) of pre-obese
mutant mice at 4 weeks of age. (H,I,L,M) Obese 12-week-old
mutant mice display reduced pSTAT3 expression in both the
ARC (H,I) and VMH (L,M), demonstrating the onset of leptin
insensitivity. DMH, dorsomedial hypothalamic nucleus;
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Leptin response is altered in the VMH and ARC
Leptin is a hormone that is released by fat tissue and is known to
have an important regulatory effect on the central control of feeding
(Elmquist et al., 1999; Schwartz et al., 2000). LepRs are expressed in
the brain, including in the VMH and ARC (Scott et al., 2009). Binding
of leptin to the LepR leads to activation of the intracellular JAK-STAT
pathway via the phosphorylation of the STAT3 transcription factor
(Ghilardi and Skoda, 1997). In order to detect any changes in leptin
response in the hypothalamus in the absence of Ngn3, pSTAT3
expression was analyzed in leptin-treated control and
Nkx2.1iCre/+;Ngn3flox/flox mice. To avoid any secondary leptin
insensitivity caused by obesity, 4-week-old pre-obese mice in addition
to 12-week-old obese animals were examined (Fig. 7F-M). In 4-week-
old mice, pSTAT3+ cells were similarly observed in the VMH and
ARC region of both control and mutant mice (Fig. 7F,G,J,K). However,
a slight reduction in pSTAT3 signal was observed in the ARC of obese
conditional mutants at 12 weeks of age (Fig. 7H,I), in line with the
previously described situation in diet-induced obese (DIO) models
(Münzberg et al., 2004; Mitchell et al., 2009). Interestingly, expression
in the VMH was greatly reduced in obese conditional mutants
(Fig. 7L,M), contrary to the DIO models in which VMH is spared
from leptin insensitivity. These results suggest that the leptin
insensitivity is a consequence rather than the cause for obesity in
Nkx2.1iCre/+;Ngn3flox/flox animals.
DISCUSSION
Arcuate anorexigenic neurons are present but not completely
differentiated in adult Nkx2.1iCre/+;Ngn3flox/flox mice
Conditional deletion of Ngn3 results in an 80% reduction in Pomc
expression in the ARC. Interestingly, Cart+ neurons persist in the
brains of adult Nkx2.1iCre/+;Ngn3flox/flox mice. This includes a
majority of Cart+ Pomc– neurons as well as a small number of Cart+
Pomc+ in the Nkx2.1iCre/+;Ngn3flox/flox ARC, whereas all ARC Cart+
cells coexpress Pomc in control mice, consistent with previous
expression studies (Vrang et al., 1999). This suggests that ARC
anorexigenic neurons are generated in Nkx2.1iCre/+;Ngn3flox/flox
mutants, albeit that a subset of these neurons do not express Pomc
and Pdyn. Altogether, these results strongly suggest that Ngn3
contributes to the specification of ARC anorexigenic neurons.
The ARC of Ngn3-null mice (Pelling et al., 2011) seems to have
a compensatory increase in Npy-expressing neurons, which is not
observed in Nkx2.1iCre/+;Ngn3flox/flox mice. This partial phenocopy
of the Ngn3-null mouse might be explained by the incomplete
deletion of Ngn3 at E9.5 (Fig. 1). We therefore suggest that a low
level of Ngn3 expression is able to drive putative ARC precursors
towards an anorexigenic fate rather than an Npy+ orexigenic fate.
However, the lack of sustained Ngn3 expression results in these
anorexigenic neurons failing to fully differentiate and express
Pomc. Interestingly, the number of Pomc+ neurons partially
recovers during development of the Ngn3-null mouse (Pelling et
al., 2011), and yet no such recovery is seen in the hypothalamus-
specific mutants. The cause for these phenotypic differences is
currently unknown and warrants further study.
Nkx2.1iCre/+;Ngn3flox/flox obesity is primarily due to loss of Pomc
products specifically in the ARC
The absence of hypothalamic Ngn3 during development results in
a partial specification of ARC neurons with the consequence that
Pomc+ neurons are largely absent. The resulting obesity can be
attributed primarily to the loss of Pomc active peptides. Pomc-null
mutant mice are hyperphagic and obese (Yaswen et al., 1999),
although not to the extent seen in Nkx2.1iCre/+;Ngn3flox/flox mice.
Pomc-null mice also exhibit no elevation in basal insulin levels, have
normal glucose tolerance and show increased insulin sensitivity
(Hochgeschwender et al., 2003). However, this surprising non-
diabetic phenotype is explained by the loss of the Pomc product
peptide Acth in the pituitary and subsequent hypocortisolism of
Pomc-null mice. When Pomc expression is rescued by transgenic
insertion of the Pomc gene specifically in the pituitary of Pomc-
null mutants, the resulting Pomc−/−Tg+ mice show amelioration of
the deficiencies due to loss of peripheral Pomc, such as adrenal
gland failure and altered glucose homeostasis (Smart et al., 2006).
When compared with Pomc−/− mice, obesity in Pomc−/−Tg+ mutants
is increased and the rate of weight gain is more rapid. There is an
increase in food intake in Pomc−/−Tg+ compared with global Pomc
nulls, the metabolic rate is decreased as indicated by reduced
oxygen consumption (VO2) and an increased respiratory exchange
ratio (referred to as RQ in this instance), and basal insulin levels
are increased in obesity (Smart et al., 2006). More recently, arcuate-
specific Pomc mutant mice have been generated, which have rapid
post-weaning obesity and associated hyperglycemia and elevated
leptin (Bumaschny et al., 2012). These phenotypes of rapid post-
weaning obesity associated with hyperphagia and decreased
metabolism are remarkably similar to those seen in the
Nkx2.1iCre/+;Ngn3flox/flox mice of the current study, strongly
suggesting that the primary cause of obesity in
Nkx2.1iCre/+;Ngn3flox/flox mice is due to loss of hypothalamic
Pomc.
Additional axes of energy balance affected in Ngn3 conditional
mutant mice
The current study presents a model for post-weaning obesity
associated with hyperphagia and correlated with reduced energy
expenditure. Yet we have only demonstrated a reduction in energy
expenditure (via locomotor activity and indirect calorimetry) in
animals that are already obese, allowing for the possibility that the
reduction observed in energy expenditure is secondary to
hyperphagic obesity. However, although it might be true that the
early increase in weight observed is due to excess feeding, genetic
evidence suggests that reduced energy expenditure might be a
primary phenotype associated with the loss of Nhlh2 expression
(Coyle et al., 2002). In addition, our results strongly suggest that
Ngn3 has an additional role in regulating energy expenditure
through Nhlh2, whose expression is severely reduced in ARC
neurons throughout embryonic development and in adult
Nkx2.1iCre/+;Ngn3flox/flox mice. Furthermore, there might also be
a compounded reduction in energy expenditure resulting from the
later insensitivity of the VMH to leptin. The mechanism underlying
this leptin insensitivity is currently unknown.
There is also a trend in Nkx2.1iCre/+;Ngn3flox/flox mutants for an
increase in circulating Pyy. Pyy is released by Ngn3-dependent
intestinal endocrine glands following feeding and acts to inhibit
feeding by binding Npy receptors. It is likely that the elevation of
Pyy is part of the normal homeostatic response trying to reduce
appetite (Karra et al., 2009). Likewise, the levels of circulating leptin
and insulin are significantly increased. Unlike the unexpected
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elevated circulating Acth levels, these responses are part of the
normal homeostatic response to excess obesity.
Ngn3 is a regulator of energy homeostasis systems throughout
the body, and is a candidate for genetic obesity and diabetes in
humans
The importance of Ngn3 in energy homeostasis is well established
via its role in pancreas islet cell and gut endocrine cell specification
(Gradwohl et al., 2000; Schonhoff et al., 2004; Mellitzer et al., 2010).
The current study, as well as the embryonic analysis of the Ngn3-
null mouse embryos (Pelling et al., 2011), highlights the importance
of Ngn3 in the development of the brain component of the feeding
control circuit. It is noteworthy that the same transcription factor
is involved in the specification of tissues involved in energy
homeostasis in both the brain and the endocrine system, although
Ngn3 acts as a proendocrine specifier in the pancreas and intestine,
whereas in the hypothalamus it gives rise to multiple neuronal fates,
not only neuroendocrine. As yet, no firm link between Ngn3 and
type 2 diabetes has been described in humans; however, the link
between obesity and type 2 diabetes is well known. Obesity and
associated diseases such as type 2 diabetes are now at epidemic
levels in western societies, due in part to increased energy
consumption and sedentary lifestyle. However, there is still variation
in obesity rates within populations living similar lifestyles. There
must therefore be a genetic or inherent component to the obesity
epidemic. The current understanding of the basis of genetic obesity
is patchy, although a number of single-nucleotide polymorphisms
(SNPs) are known. Although Ngn3 disruption in the endocrine
system seems to have a greater effect upon patient outcomes for
those few known cases than any changes in the hypothalamus
(Wang et al., 2006; Pinney et al., 2011), the direct targets of Ngn3
in the hypothalamus are still unclear. As such, better understanding
of the action of Ngn3 within the hypothalamus might illuminate
further the basis of genetic obesity in humans.
MATERIALS AND METHODS
Generation of conditional knockout mice
In order to study the consequence of deletion of Ngn3 in the
hypothalamus throughout development, mice that are homozygous
for the floxed Ngn3 allele (Ngn3flox/flox) were generated as previously
described (Mellitzer et al., 2010). Female Ngn3flox/flox mice were then
crossed with male mice carrying a single copy of the Nkx2.1iCre
allele. The resulting male mice were crossed again with Ngn3flox/flox
female mice to generate homozygous conditional-knockout
Nkx2.1iCre/+;Ngn3flox/flox mutant mice, and control Ngn3flox/flox
littermates.
qRT-PCR
Control and mutant embryos were collected at E9.5 (n=3), and the
ventral forebrain was immediately dissected and collected into 0.5
ml tubes containing 50 μl of Arcturus PicoPure extraction buffer,
and RNA extracted using the Arcturus PicoPure RNA isolation
system (Applied Biosystems, Carlsbad, CA). Similarly, E15.5
pancreata (n≥3) were dissected and immediately placed in 100 μl
of extraction buffer and RNA was extracted in the same manner.
cDNA was made using Superscript III First Strand Synthesis kit
(Life Technologies, Paisley, UK). qRT-PCR was carried out using
the following primer pair against Ngn3 mRNA: Fwd 5-
GGATGACGCCAAACTTACAAA-3, Rev 5-AGAAGCTGTG -
GTCCGCTATG-3. Ngn3 levels were then expressed as % Gapdh
[100×2–ΔCT)] by normalization against Gapdh expression detected
with the following primer pair: Fwd 5-AATCCCATCAC -
CATCTTCCA-3, Rev 5-GGCAGTGATGGCATGGACTG-3.
Slide preparation
Embryonic tissue was prepared for in situ hybridization and
immunohistochemistry in the following manner. Whole embryos
were dissected at E9.5, E10.5 and E13.5, and embryonic brains
dissected at E15.5 and E17.5, and fixed overnight in 4%
paraformaldehyde (PFA), before being washed in DEPC-treated
PBS and cryopreserved overnight in filtered 30% sucrose/DEPC-
treated PBS. Tissue was then embedded in OCT medium, frozen
for coronal sectioning on dry ice and stored at −20°C or −80°C
until required. Adult mice were placed into terminal anesthesia
by an intraperitoneal (i.p.) injection of 50 mg pentobarbital/kg
body weight. Once fully anesthetized, mice were transcardially
perfused with 0.5% saline followed by 25-50 ml of 4% PFA
depending on body mass. Once perfusion was complete, the
brains and large intestines were collected and post-fixed overnight
in 4% PFA, before being processed for cryosectioning as described
above. Coronal sections were made at −20°C with a cryostat
(Leica, Nussloch, Germany) and hypothalamic tissue mounted on
Superfrost Plus slides, air dried and stored at −80°C until required.
E9.5 and E10.5 embryos were sectioned at 10 μm and mounted
over a series of four slides; E13.5 and E15.5 embryos were
sectioned at 12 μm and mounted over a series of six slides; and
E17.5 and postnatal stages were sectioned at 14 μm and mounted
over a series of eight slides. In order to minimize variations in
gene expression due to normal diurnal changes, all tissue was
collected between 1 and 3 hours before the onset of the normal
12-hour dark phase (2-4 pm).
In situ hybridization and immunohistochemistry
In situ hybridization was carried out as previously described
(Vernay et al., 2005). The following antisense RNA probes were
used: Ngn3 (Gradwohl et al., 2000), Pomc (Good et al., 1997), Npy
(Higuchi et al., 1988), Nhlh2 (Good et al., 1997), Cart (Image clone
#466874), Th (Grima et al., 1985). An antisense mRNA probe
against Pdyn was made from a cDNA template as previously
described (Krawchuk and Kania, 2008). The cDNA was derived
from adult mouse hypothalamus tissue and the probe generated
using the following primer pair: Fwd 5-CCCCCTGATTTG -
CTCCCTGGAGT-3, Rev (including T7 site) 5-GGTAATA -
CGACTCACTATAGGGTGAACTGACGCCGCAGGAAACC-3.
Two-color fluorescence in situ hybridization was carried out with
digoxygenin-labeled antisense mRNA probes against Cart and
fluorescein-labeled probes against either Pomc or Npy and revealed
with fast red and Alexa-Fluor-488-conjugated TSA kit (Life
Technologies) as previously described (Ishii et al., 2004), before
mounting with Prolong Gold antifade reagent with DAPI (Life
Technologies).
For immunohistochemistry to detect Erα and αMSH, sections
were incubated overnight at 4°C with rabbit anti-Erα primary
antibody (Millipore, Temecula, CA) diluted 1/200 in blocking
solution (0.1% Triton X-100 and 1% BSA in PBS) or rabbit anti-
αMSH primary antibody (Millipore) diluted 1/10,000 in blocking
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solution. Sections were then extensively washed in PBS and
incubated for 2 hours at room temperature with a donkey anti-
rabbit secondary antibody conjugated with Fitc (for Erα) or Cy3
(for αMSH) (both Stratech, Newmarket, UK). Sections were then
extensively washed and mounted in Prolong Gold antifade reagent
with DAPI (Life Technologies, Paisley, UK). Immunohistochemistry
using anti-pSTAT3 (Cell Signaling, Danvers, MA) was carried out
as previously described (Münzberg et al., 2003) with the following
modifications: overnight fasted mice were treated by i.p. injection
with 5 mg human recombinant leptin/kg body weight (R&D
Systems, Abingdon, UK) 45 minutes before being perfused with
2% PFA, post-fixed overnight and processed to generate slides.
Defrosted sections were then washed in PBS followed by a 30-
minute treatment in 50% ice-cold methanol, 5% H2O2. Slides were
then washed extensively and incubated overnight at 4°C with rabbit
anti-pSTAT3 primary antibody diluted in blocking solution.
Washed sections were then incubated for 2 hours with biotinylated
anti-rabbit secondary antibodies (Vector Laboratories,
Peterborough, UK), the signal amplified with ABC Vecastain kit
(Vector Laboratories) and revealed with DAB-Ni (Vector
Laboratories). Slides were then dehydrated through a graded
ethanol series to prevent loss of DAB-Ni stain, and mounted in
DePX mounting medium.
All immunohistochemistry and in situ hybridization experiments
were repeated with tissue from at least three separate individuals
(n≥3), and in both male and female mice.
Image analysis and cell counting
Fluorescence in situ hybridization and immunohistochemistry
images were then obtained with a Leica TCS SP2 (Leica) confocal
microscope. Colorimetric stains were imaged with a Zeiss LSM510
microscope (Carl Zeiss, Oberkochen, Germany) connected to a
computer running Axioplan2.1 imaging software. Images were
processed with Adobe Photoshop CS5 and NIH ImageJ
(http://rsbweb.nih.gov/ij/).
All cell counts were carried out using the Cell Counter plug-in
for ImageJ. Cell counts were derived from an average of three counts
of whole cell nuclei from a single series of cryostat-cut sections per
animal, with a mean taken from a minimum of three series per
expression pattern of interest (n≥3). All positive cells from either
the left or right side hemisphere were counted across the whole
anterior-posterior axis of the ARC each series. Only ARC Npy-
expressing cells were counted, excluding those found in the DMH
and elsewhere. All counts were carried out with the operator blind
as to the genotype of the sample being counted. Student’s t-test
was then carried out to compare the control and conditional mutant
counts for statistical significance (P<0.05).
Physiological and behavioral assays
All physiological and behavioral studies were carried out on the
same cohort of 36 mice transported at 8 weeks of age from the UK
to the Mouse Clinical Institute, Illkirch, France. This cohort
included 18 Nkx2.1iCre/+;Ngn3flox/flox mice and 18 control
(Ngn3flox/flox) controls; 9 males and 9 females of each genotype. Body
weight was measured weekly from the age of 12 to 22 weeks, and
food intake was measured daily between the age of 12 to 14 weeks,
with the mice housed one to three individuals per cage. For paired-
feeding experiments, daily food consumption of individually housed
ad libitum-fed control mice was measured (n=3) between 4 and 6
weeks of age. Individually housed Nkx2.1iCre/+;Ngn3flox/flox
littermate mice were then either restricted in their food by the
amount consumed by the control mice the previous night (n=3),
or allowed to feed ad libitum (n=3). All mice were weighed at the
beginning of the experiment followed by twice-weekly
measurements and the mean weight gain compared. Mice were fed
standard lab chow throughout the experiment (Labdiet,
Autoclavable Laboratory Animal Diet 5021).
Body composition
Body composition was measured in conscious 14-week-old mice
(n=9 for each sex and genotype) by qNMR using the Minispec
analyzer (Bruker, Karlsruher, Germany).
Energy expenditure
Following body composition analysis, energy expenditure was then
evaluated at 17 weeks by O2 consumption, CO2 production, heat
production and activity, monitored using the TSE Labmaster (TSE
Systems, Bad Homburg, Germany) (n=9 for each sex and genotype).
Following 24 hours acclimatization, analysis was carried out over
a 24-hour period including a 12-hour dark photoperiod and 12
hours light.
Intraperitoneal glucose tolerance test and insulin sensitivity test
Glucose and insulin sensitivity was measured in the same cohort
of mice (n=9 for each sex and genotype) at 19 and 21 weeks by i.p.
injection of a standardized 2 g dose of glucose/kg body weight (at
19 weeks) or 0.5 UI insulin/kg body weight (at 21 weeks) following
a period of fasting (16 hours glucose tolerance test, 2 hours insulin
sensitivity test). Following i.p. challenge, blood was obtained from
the tail and glucose was measured by use of a blood glucose monitor
and glucose test strips (Roche Diagnostics, Accu-Chek) at different
time points (over 180 minutes in the case of the glucose tolerance
test, and 90 minutes in the insulin sensitivity test). All tests were
conducted during the light period.
Blood analysis
Blood was collected from 23-week-old mice (n=9 for each sex and
genotype) by retro orbital puncture under isoflurane anesthesia
following 4 hours of fasting. Plasma insulin, leptin and Pyy were
measured with a BioPlex analyzer using Milliplex beads (Millipore).
Adiponectin was measured by ELISA using the Quantikine
Adiponectin/Acrp30 immunoassay (R&D Systems). Acth was
measured by RIA using the ImmunoChem double antibody 
Acth 125I RIA kit (MP Biomedical).
Statistical analysis
All comparisons between Nkx2.1iCre/+;Ngn3flox/flox mice and
controls were performed using ANOVA test followed by Student’s
t-test.
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